RealFeedApp ARDD data confirm semaglutide and tirzepatide slow molecular aging measures
The companies presented early data suggesting semaglutide and tirzepatide may slow molecular measures of biological aging. In a study of 10,052 people, proteomic clock differences ranged from two to three years, while Lilly's sub-study showed all 15 age-unit clocks lagged 1.38 years behind chronological time.
- Field
- ageing and longevity
- What they did
- Researchers demonstrated that semaglutide and tirzepatide may slow molecular measures of biological aging, with one protein-based clock lagging behind chronological time by 2 to 4 years.
- Why it matters
- This could help understand how diabetes and obesity medications affect the aging process in the human body.
#semaglutide#tirzepatide#biological aging#ardd#glp-1
